Senti Biosciences (SNTI) Current Deferred Revenue (2021 - 2025)
Senti Biosciences' quarterly Current Deferred Revenue came in at $43000.0 in Q4 2025, down 88.06% quarter-over-quarter from $360000.0 in Q2 2025.
Senti Biosciences has reported Current Deferred Revenue for 5 years, with the latest figure at $43000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue changed N/A year-over-year to $43000.0; the trailing twelve-month figure through Dec 2025 stood at $43000.0 (changed N/A YoY), and the FY2025 full-year result was $43000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $43000.0, down from $360000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.7 million in Q4 2021, with the low at $43000.0 in Q4 2025.
- Average Current Deferred Revenue over 5 years is $627846.2, with a median of $639000.0 recorded in 2024.
- Year-over-year, Current Deferred Revenue sank 80.31% in 2023 and jumped 386.59% in 2024.
- Tracing SNTI's Current Deferred Revenue over 5 years: stood at $1.7 million in 2021, then tumbled by 51.75% to $799000.0 in 2022, then climbed by 23.78% to $989000.0 in 2023, then slumped by 35.39% to $639000.0 in 2024, then slumped by 93.27% to $43000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $43000.0 (Q4 2025), $360000.0 (Q2 2025), and $513000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Sep 30, 2024 | 639,000.00 |
| Jun 30, 2024 | 798,000.00 |
| Mar 31, 2024 | 862,000.00 |
| Dec 31, 2023 | 989,000.00 |
| Jun 30, 2023 | 164,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 799,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 833,000.00 |
| Dec 31, 2021 | 1.66 Mn |